These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7283364)

  • 1. An assessment of radioimmunoassay procedures for determination of anti-acetylcholine receptor antibodies in the sera of patients with myasthenia gravis.
    Carter B; Harrison R; Lunt GG; Morris H; Savage-Marengo T; Stephenson FA
    Ann Clin Biochem; 1981 May; 18(Pt 3):146-52. PubMed ID: 7283364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Heterogeneity of antibodies blocking the binding of bungarotoxin to the acetylcholine receptor in myasthenia].
    Vernet-der-Garabédian B; Morel E; Bach JF
    C R Acad Sci III; 1984; 298(16):449-56. PubMed ID: 6428718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of antibodies directed against the alpha-bungarotoxin binding site on human acetylcholine receptor and severity of myasthenia gravis.
    Vernet-der Garabedian B; Morel E; Bach JF
    J Neuroimmunol; 1986 Jul; 12(1):65-74. PubMed ID: 3711314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic studies on neurotoxin-binding inhibitory antibodies in myasthenia gravis.
    Ito A; Furukawa S; Satoyoshi E; Sakurai H
    Clin Chim Acta; 1985 Nov; 152(3):315-23. PubMed ID: 2998645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphologic and immunologic studies in experimental autoimmune myasthenia gravis and myasthenia gravis.
    Trotter JL; Ringel SP; Cook JD; Engel WK; Eldefrawi ME; McFarlin DE
    Neurology; 1977 Dec; 27(12):1120-4. PubMed ID: 73154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of alpha-fetoprotein on the binding of myasthenia gravis antibody to acetylcholine receptor.
    Brenner T; Beyth Y; Abramsky O
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3635-9. PubMed ID: 6158053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acetylcholine receptor antibodies in the diagnosis of myasthenia gravis. Study of 406 confirmed cases].
    Toyka KV; Heininger K
    Dtsch Med Wochenschr; 1986 Sep; 111(38):1435-9. PubMed ID: 3757800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Demonstration of acetylcholine receptor antibodies in the serum of myasthenia gravis patients applying affinity chromatographically purified human acetylcholine receptor preparations (author's transl)].
    Kalies I; Kalden JR; Heinz F; Janzen RW; Lachenmayer L
    Klin Wochenschr; 1979 Sep; 57(17):875-81. PubMed ID: 502355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylcholine receptor in myasthenia gravis: increased affinity for alpha-bungarotoxin.
    Elias SB; Appel SH
    Ann Neurol; 1978 Sep; 4(3):250-2. PubMed ID: 718136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha-Bungarotoxin and anti-acetylcholine receptor antibody binding to the human acetylcholine receptor.
    Vincent A; Newsom-Davis J
    Adv Cytopharmacol; 1979; 3():269-78. PubMed ID: 474297
    [No Abstract]   [Full Text] [Related]  

  • 11. Radioimmunoassay of antibodies to acetylcholine receptor in serum of myasthenia gravis patients.
    Brenner T; Abramsky O; Lisak RP; Zweiman B; Tarrab-Hazdai R; Fuchs S
    Isr J Med Sci; 1978 Sep; 14(9):986-9. PubMed ID: 721428
    [No Abstract]   [Full Text] [Related]  

  • 12. Myasthenia gravis: antibodies to acetylcholine receptor with human and rat antigens.
    Oda K; Goto I; Kuroiwa Y; Onoue K; Ito Y
    Neurology; 1980 May; 30(5):543-6. PubMed ID: 7189261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha-Bungarotoxin displacing antibody in myasthenia gravis.
    Barkas T; Simpson JA
    J Clin Lab Immunol; 1982 Nov; 9(2):113-7. PubMed ID: 7154056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of anti-acetylcholine receptor antibodies in Praomys (Mastomys) natalensis.
    Vincent A; Solleveld HA
    Clin Exp Immunol; 1981 Jan; 43(1):94-8. PubMed ID: 7249398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and characterization of blocking-type anti-acetylcholine receptor antibodies in sera from patients with myasthenia gravis.
    Hara H; Hayashi K; Ohta K; Itoh N; Nishitani H; Ohta M
    Clin Chem; 1993 Oct; 39(10):2053-7. PubMed ID: 8403390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of alpha-bungarotoxin binding to acetylcholine receptors by antisera from animals with experimental autoimmune myasthenia gravis.
    Claudio T; Raftery MA
    J Supramol Struct; 1980; 14(3):267-79. PubMed ID: 6971372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus.
    Schwimmbeck PL; Dyrberg T; Drachman DB; Oldstone MB
    J Clin Invest; 1989 Oct; 84(4):1174-80. PubMed ID: 2551924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of myasthenic serum globulin with the acetylcholine receptor.
    Almon RR; Appel SH
    Biochim Biophys Acta; 1975 May; 393(1):66-77. PubMed ID: 1138925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple forms of anti-acetylcholine receptor antibody in myasthenia gravis.
    Mittag T; Massa T; Kornfeld P; Papatestas A; Bender A; Genkins G
    Muscle Nerve; 1981; 4(1):16-25. PubMed ID: 6164920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myasthenia gravis: antibodies to acetylcholine receptor in ocular myasthenia gravis.
    Oda K; Ito Y
    J Neurol; 1981; 225(4):251-8. PubMed ID: 6169804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.